Highlights the risk of life-threatening bleeding in patients with an unusual excessive response to dabigatran, with implications for emergency surgery and resuscitation.
No takes yet. Share an insight, caveat, or question.
Wolf et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: